Fortitude Family Office, LLC Immunity Bio, Inc. Transaction History
Fortitude Family Office, LLC
- $430 Billion
- Q4 2025
A detailed history of Fortitude Family Office, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 34 shares of IBRX stock, worth $70. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 44
22.73%
Holding current value
$70
Previous $108,000
37.96%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IBRX
# of Institutions
302Shares Held
137MCall Options Held
2.59MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA27.7MShares$57.5 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY12.8MShares$26.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.3MShares$23.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$14.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $833M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...